Gene Therapy for Severe Combined Immunodeficiency due to Adenosine Deaminase Deficiency

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|12|1|57-65

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.12, Iss.1, 2012-02, pp. : 57-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imidazole-4-carboxamide derivatives as inhibitors of adenosine deaminase

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 4, 2004-04 ,pp. : 573-576

Informa Healthcare

Access to resources Recommend Favorite

Non-nucleoside adenosine deaminase inhibitors: 2000 – 2004

By Terasaka Tadashi  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 7, 2005-07 ,pp. : 817-828

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy for Primary Immunodeficiency Diseases: Recent Progress and Misgivings

By  

Current Pharmaceutical Design, Vol. 12, Iss. 5, 2006-02 ,pp. : 549-556

Bentham Science Publishers

Access to resources Recommend Favorite

BCG vaccine: Disseminated BCG infection in an infant with x-linked severe combined immunodeficiency: case report

By  

Reactions Weekly, Vol. 1, Iss. 1252, 2009-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Rotavirus vaccine: Rotavirus infection in infants with severe combined immunodeficiency: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1292, 2010-01 ,pp. : 33-33

Adis International

Access to resources Recommend Favorite